Becton, Dickinson and Co. (BDX) said Wednesday it plans to increase capacity for critical medical devices by making new investments in its manufacturing facilities in the US.
The company intends to invest more than $30 million this year to increase manufacturing capacity for IV lines at its Utah plant.
Becton, Dickinson said it installed new needle and syringe production lines at its plants in Connecticut and Nebraska as part of its 2024 investment of more than $10 million. One line is now fully operational, while additional lines are likely to start up in the coming months, the company said.
Price: 235.45, Change: -0.35, Percent Change: -0.15
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。